Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL129777 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CNR1CNR2 | |
| SCHEMBL131835 | 0.99 | CNR1 (0.40) | ALDH1A1CNR1CNR2 | |
| SCHEMBL129695 | 0.99 | CNR1 (0.40) | ALDH1A1CNR1CNR2 | |
| SCHEMBL14617185 | 0.91 | ALDH1A1 (0.45) | ALDH1A1CNR1CNR2 | |
| SCHEMBL129691 | 0.91 | ALDH1A1 (0.45) | ALDH1A1CNR1CNR2 | |
| SCHEMBL130742 | 0.91 | ALDH1A1 (0.45) | ALDH1A1CNR1CNR2 | |
| SCHEMBL14617186 | 0.91 | ALDH1A1 (0.45) | ALDH1A1CNR1CNR2 | |
| SCHEMBL25849269 | 0.90 | CNR1 (0.44) | ALDH1A1CNR1CNR2 | |
| SCHEMBL20127926 | 0.90 | CNR1 (0.44) | ALDH1A1CNR1CNR2 | |
| SCHEMBL16359217 | 0.87 | LPAR2 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226096-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226096-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | RTCB, HNRNPA1, HNRNPAB | ALDH1A1 4484/4885CNR1 4579/4885CNR2 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.